In Indian stock markets, Rakesh Jhunjhunwala needs no introduction. Popularly called the “Big Bull”, he is the most successful non-promoter investor in India. With a portfolio worth Rs.20,000 crore, some of his top picks are almost as popular as

Going by the recent reports it looks like the BEML stock may be ripe for divesting by the government. As per the latest reports in the press, the government may have just about shortlisted the potential candidates for taking over the 26 stake in BEM

Policybazaar was touted as one of the big digital IPOs of 2022 along with other names like Zomato, Paytm, Nykaa and MobiKwik. The emphatic success of the Zomato IPO has forced the other digital candidates to fast-track their IPO plans. With Paytm and

The auto ancillary industry in India has been largely centered around NCR, Tamil Nadu and Maharashtra, which is obviously due to their proximity to auto manufacturing hubs. Rolex Rings manufactures hot-rolled forged and machine bearing rings and othe

NFOs or new fund offerings have been the mutual fund equivalent of equity IPOs. But, the big challenge was to have a unique theme to offer to customers. SEBI has restricted fund houses to launching just 1 fund per defined category, so the NFO scope w

Nuvoco Vistas may not be a well-known name in market circles, but it is already a formidable name in cement circles. Now SEBI has approved the proposal of Nuvoco Vistas IPO, which is expected to be worth Rs.5,000 crore. This will consist of a fresh i

We normally tend to use the words trading holiday and clearing holiday in the stock markets interchangeably. These are two different things altogether. The trading holiday is the day on which there is no trading permitted. That means you cannot use y

Glenmark Life Sciences joined the list of big ticket IPOs making a public offer. The company was incorporated in 2011 as a wholly-owned subsidiary of Glenmark Pharma. Indian Pharma industry is divided into Active Pharma Ingredients (APIs), CRAMs and

If you have been tracking pharma industry in the past, you would have heard of this popular product called APIs. The active pharma ingredients (APIs) are the specialized raw inputs that go into manufacture of medicines. One of India’s leading playe

The early indications were that Tatva Chintan IPO would get comfortably oversubscribed. However, at close on Tuesday, the overall issue got oversubscribed by a solid 180.35 times. The Rs.500 crore IPO of Tatva Chintan consisted of Rs.225 crore of fre

IPO investors generally have questions such as “No shares allotted to me in IPO, why?”, “I haven’t got any allotment in multiple applications” “why I am not getting allotment in any of the IPOs?”. Thus, it is clear that the lucky people

In the last two months, the proposed Rs.4,000 crore preferential offer by PNB Housing to Carlyle has become the bone of contention. The first objection to the deal came from proxy firm SES. Shareholder Empowerment Firm (SES) is run by former SEBI ED,